<DOC>
	<DOCNO>NCT00092040</DOCNO>
	<brief_summary>The purpose study 12 month extension evaluate effect two investigational drug osteoporosis postmenopausal woman .</brief_summary>
	<brief_title>A Study 12 Month Extension Evaluate Two Investigational Drugs Postmenopausal Women With Osteoporosis ( MK-0217-907 )</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Osteoporosis , Postmenopausal</mesh_term>
	<mesh_term>Alendronate</mesh_term>
	<mesh_term>Risedronate Sodium</mesh_term>
	<criteria>Postmenopausal woman osteoporosis Any know allergy study drug</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>